PharmaFab Revising Standard Operating Procedures After FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
The company modifies its processes for batch reprocessing, stability testing and purified water handling after FDA cites production shortcomings. The Texas facility produces tablet, capsules and liquid cough and cold products.